| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 71 | 2024 | 1063 | 5.840 |
Why?
|
| Erythrocytes | 107 | 2024 | 2413 | 5.300 |
Why?
|
| Reticulocytes | 29 | 2022 | 288 | 3.440 |
Why?
|
| Anemia, Iron-Deficiency | 17 | 2024 | 369 | 3.080 |
Why?
|
| Symporters | 30 | 2022 | 363 | 2.800 |
Why?
|
| Potassium | 61 | 2022 | 1309 | 2.490 |
Why?
|
| Erythrocytes, Abnormal | 18 | 2018 | 121 | 1.960 |
Why?
|
| Hemoglobins | 34 | 2021 | 1525 | 1.940 |
Why?
|
| Erythrocyte Membrane | 32 | 2015 | 438 | 1.940 |
Why?
|
| beta-Thalassemia | 13 | 2023 | 236 | 1.910 |
Why?
|
| Hematology | 4 | 2024 | 243 | 1.510 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 13 | 2022 | 45 | 1.420 |
Why?
|
| Erythropoiesis | 18 | 2018 | 683 | 1.390 |
Why?
|
| Clotrimazole | 22 | 2008 | 76 | 1.390 |
Why?
|
| Editorial Policies | 16 | 2016 | 458 | 1.380 |
Why?
|
| Chlorides | 30 | 2022 | 657 | 1.340 |
Why?
|
| Blood Cell Count | 6 | 2021 | 396 | 1.140 |
Why?
|
| Erythrocyte Indices | 18 | 2019 | 144 | 1.110 |
Why?
|
| Hemoglobin, Sickle | 17 | 2022 | 113 | 1.080 |
Why?
|
| Anemia, Hemolytic, Congenital | 9 | 2019 | 71 | 1.060 |
Why?
|
| Hydrops Fetalis | 9 | 2019 | 113 | 1.040 |
Why?
|
| Hematologic Diseases | 4 | 2021 | 496 | 1.040 |
Why?
|
| Erythropoietin | 21 | 2006 | 719 | 1.030 |
Why?
|
| Ion Transport | 18 | 2017 | 319 | 1.020 |
Why?
|
| Magnesium | 14 | 2011 | 804 | 1.010 |
Why?
|
| Reticulocyte Count | 14 | 2021 | 36 | 1.000 |
Why?
|
| Automation, Laboratory | 2 | 2024 | 102 | 0.980 |
Why?
|
| Iron | 21 | 2023 | 1790 | 0.970 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 2 | 2021 | 21 | 0.930 |
Why?
|
| Hydroxyurea | 14 | 2021 | 284 | 0.910 |
Why?
|
| Potassium Channels, Calcium-Activated | 7 | 2005 | 43 | 0.860 |
Why?
|
| Cations | 13 | 2022 | 238 | 0.850 |
Why?
|
| Spherocytosis, Hereditary | 9 | 2024 | 83 | 0.830 |
Why?
|
| Antisickling Agents | 9 | 2014 | 72 | 0.770 |
Why?
|
| Journalism, Medical | 4 | 2016 | 73 | 0.770 |
Why?
|
| Hemolysis | 13 | 2021 | 415 | 0.770 |
Why?
|
| Sulfones | 2 | 2021 | 448 | 0.750 |
Why?
|
| Iron Compounds | 1 | 2021 | 28 | 0.750 |
Why?
|
| Potassium Channels | 17 | 1999 | 537 | 0.750 |
Why?
|
| Trityl Compounds | 5 | 2021 | 13 | 0.740 |
Why?
|
| Sodium | 29 | 2013 | 1589 | 0.740 |
Why?
|
| Potassium Channel Blockers | 8 | 2017 | 161 | 0.700 |
Why?
|
| Adenoidectomy | 2 | 2020 | 167 | 0.680 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 11 | 2011 | 150 | 0.670 |
Why?
|
| Acetamides | 5 | 2021 | 257 | 0.640 |
Why?
|
| Periodicals as Topic | 8 | 2016 | 1463 | 0.620 |
Why?
|
| Erythrocyte Count | 11 | 2021 | 157 | 0.610 |
Why?
|
| Tonsillectomy | 2 | 2020 | 277 | 0.600 |
Why?
|
| Specimen Handling | 10 | 2014 | 702 | 0.600 |
Why?
|
| Postoperative Hemorrhage | 2 | 2020 | 416 | 0.590 |
Why?
|
| Calcium | 25 | 2010 | 5719 | 0.580 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 381 | 0.570 |
Why?
|
| Anemia, Hypochromic | 3 | 2015 | 63 | 0.550 |
Why?
|
| Carrier Proteins | 22 | 2019 | 4935 | 0.550 |
Why?
|
| Piperazines | 4 | 2023 | 2522 | 0.550 |
Why?
|
| Ion Channels | 12 | 2019 | 1038 | 0.520 |
Why?
|
| Anemia, Hemolytic | 4 | 2023 | 163 | 0.510 |
Why?
|
| Disclosure | 9 | 2012 | 747 | 0.500 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2015 | 87 | 0.480 |
Why?
|
| Blood Proteins | 5 | 2012 | 1173 | 0.460 |
Why?
|
| Biological Transport | 33 | 2015 | 2080 | 0.460 |
Why?
|
| Fetal Hemoglobin | 14 | 2023 | 345 | 0.460 |
Why?
|
| Pyrrolidonecarboxylic Acid | 4 | 2007 | 65 | 0.460 |
Why?
|
| Blood Chemical Analysis | 2 | 2014 | 436 | 0.450 |
Why?
|
| Dehydration | 10 | 2019 | 216 | 0.450 |
Why?
|
| Water-Electrolyte Balance | 9 | 2001 | 325 | 0.440 |
Why?
|
| von Willebrand Diseases | 1 | 2015 | 132 | 0.430 |
Why?
|
| Point-of-Care Systems | 2 | 2021 | 1212 | 0.420 |
Why?
|
| Phosphoprotein Phosphatases | 5 | 2005 | 328 | 0.420 |
Why?
|
| Quantitative Trait Loci | 6 | 2017 | 2113 | 0.410 |
Why?
|
| Hemoglobin SC Disease | 5 | 2022 | 23 | 0.400 |
Why?
|
| Anemia | 10 | 2019 | 1504 | 0.400 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 5 | 2010 | 59 | 0.390 |
Why?
|
| Humans | 222 | 2024 | 761208 | 0.390 |
Why?
|
| Antiporters | 5 | 2004 | 276 | 0.370 |
Why?
|
| von Willebrand Factor | 1 | 2015 | 677 | 0.370 |
Why?
|
| Mice | 76 | 2024 | 81326 | 0.360 |
Why?
|
| Ferritins | 10 | 2021 | 596 | 0.360 |
Why?
|
| Clinical Medicine | 4 | 2012 | 145 | 0.360 |
Why?
|
| Clinical Laboratory Techniques | 6 | 2012 | 746 | 0.340 |
Why?
|
| Animals | 104 | 2024 | 168079 | 0.340 |
Why?
|
| Hematologic Tests | 5 | 2024 | 239 | 0.340 |
Why?
|
| Chromosomes, Mammalian | 1 | 2010 | 147 | 0.340 |
Why?
|
| beta-Globins | 1 | 2010 | 111 | 0.340 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 13 | 2013 | 476 | 0.330 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2008 | 8 | 0.320 |
Why?
|
| Reference Values | 15 | 2021 | 4921 | 0.310 |
Why?
|
| Reperfusion Injury | 2 | 2024 | 1026 | 0.310 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2000 | 278 | 0.300 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2008 | 34 | 0.300 |
Why?
|
| Mutation, Missense | 6 | 2019 | 2567 | 0.290 |
Why?
|
| Automation | 2 | 2024 | 585 | 0.290 |
Why?
|
| Hydrogen-Ion Concentration | 15 | 2022 | 2477 | 0.290 |
Why?
|
| Erythroblasts | 4 | 2014 | 142 | 0.290 |
Why?
|
| Forkhead Transcription Factors | 4 | 2021 | 1613 | 0.290 |
Why?
|
| Disease Models, Animal | 26 | 2024 | 18220 | 0.290 |
Why?
|
| Spherocytes | 2 | 2012 | 9 | 0.280 |
Why?
|
| Hyperkalemia | 3 | 2016 | 233 | 0.280 |
Why?
|
| Erythrocyte Volume | 6 | 2007 | 28 | 0.280 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2008 | 213 | 0.280 |
Why?
|
| Ethylmaleimide | 5 | 2001 | 69 | 0.280 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2576 | 0.270 |
Why?
|
| Genomics | 2 | 2021 | 5828 | 0.270 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2008 | 352 | 0.270 |
Why?
|
| Nitroso Compounds | 1 | 2006 | 71 | 0.260 |
Why?
|
| Multiple Myeloma | 2 | 2023 | 5145 | 0.260 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2006 | 64 | 0.260 |
Why?
|
| Osmotic Fragility | 8 | 2019 | 35 | 0.250 |
Why?
|
| Serum Albumin, Bovine | 1 | 2006 | 319 | 0.250 |
Why?
|
| Hematinics | 1 | 2008 | 282 | 0.250 |
Why?
|
| Scorpion Venoms | 2 | 1995 | 29 | 0.240 |
Why?
|
| Haplotypes | 2 | 2010 | 2715 | 0.230 |
Why?
|
| Dietary Supplements | 5 | 2017 | 3410 | 0.230 |
Why?
|
| Mice, Transgenic | 18 | 2021 | 9520 | 0.230 |
Why?
|
| Osmolar Concentration | 8 | 2006 | 659 | 0.230 |
Why?
|
| Torque teno virus | 1 | 2024 | 13 | 0.230 |
Why?
|
| Plasmodium knowlesi | 2 | 2015 | 23 | 0.230 |
Why?
|
| Cell Size | 8 | 2019 | 625 | 0.230 |
Why?
|
| Administration, Oral | 11 | 2021 | 4015 | 0.230 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2008 | 790 | 0.230 |
Why?
|
| Genetic Variation | 6 | 2017 | 6567 | 0.220 |
Why?
|
| Iron Overload | 2 | 2023 | 239 | 0.220 |
Why?
|
| Hematocrit | 14 | 2012 | 623 | 0.220 |
Why?
|
| Membrane Proteins | 10 | 2014 | 7851 | 0.220 |
Why?
|
| Transferrin | 4 | 2021 | 283 | 0.220 |
Why?
|
| Doping in Sports | 2 | 2000 | 62 | 0.220 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 3691 | 0.220 |
Why?
|
| Pyruvate Kinase | 2 | 2023 | 189 | 0.210 |
Why?
|
| alpha-Thalassemia | 2 | 2014 | 52 | 0.210 |
Why?
|
| Potassium Chloride | 2 | 2003 | 229 | 0.210 |
Why?
|
| Administrative Personnel | 2 | 1994 | 183 | 0.210 |
Why?
|
| Antifungal Agents | 6 | 1997 | 752 | 0.210 |
Why?
|
| Conflict of Interest | 4 | 2011 | 554 | 0.210 |
Why?
|
| Hemoglobin C Disease | 3 | 1989 | 8 | 0.210 |
Why?
|
| Receptors, Erythropoietin | 2 | 2022 | 144 | 0.210 |
Why?
|
| Recombinant Proteins | 18 | 2004 | 6504 | 0.210 |
Why?
|
| Oxidative Stress | 5 | 2007 | 3114 | 0.200 |
Why?
|
| Vasodilator Agents | 2 | 2006 | 989 | 0.200 |
Why?
|
| Ouabain | 10 | 2011 | 246 | 0.200 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 7 | 2006 | 106 | 0.200 |
Why?
|
| Male | 83 | 2024 | 360693 | 0.200 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2024 | 249 | 0.200 |
Why?
|
| Bumetanide | 8 | 2006 | 98 | 0.200 |
Why?
|
| Hydrocephalus | 2 | 2000 | 764 | 0.200 |
Why?
|
| Cell Count | 5 | 2017 | 1831 | 0.200 |
Why?
|
| Erythrocyte Aging | 5 | 2012 | 53 | 0.200 |
Why?
|
| Athletes | 2 | 2021 | 1138 | 0.200 |
Why?
|
| Calpain | 2 | 2012 | 146 | 0.200 |
Why?
|
| Infusions, Intravenous | 3 | 2021 | 2217 | 0.200 |
Why?
|
| Erythrocyte Deformability | 5 | 2017 | 55 | 0.200 |
Why?
|
| Nitric Oxide | 4 | 2006 | 2136 | 0.190 |
Why?
|
| Calcium Channel Blockers | 3 | 2002 | 691 | 0.190 |
Why?
|
| DNA Virus Infections | 1 | 2021 | 15 | 0.190 |
Why?
|
| Imidazoles | 4 | 1996 | 1172 | 0.190 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1995 | 1535 | 0.190 |
Why?
|
| Hemoglobin A | 3 | 1999 | 84 | 0.190 |
Why?
|
| Enzyme Activators | 1 | 2021 | 57 | 0.190 |
Why?
|
| Anemia, Dyserythropoietic, Congenital | 1 | 2001 | 15 | 0.190 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2016 | 563 | 0.190 |
Why?
|
| Thalassemia | 3 | 1999 | 267 | 0.180 |
Why?
|
| Pathology | 2 | 1994 | 269 | 0.180 |
Why?
|
| Ion Channel Gating | 4 | 1999 | 428 | 0.180 |
Why?
|
| Blood Donors | 2 | 1993 | 345 | 0.180 |
Why?
|
| Rheology | 2 | 2019 | 347 | 0.180 |
Why?
|
| Female | 78 | 2021 | 392544 | 0.180 |
Why?
|
| Flow Cytometry | 7 | 2021 | 5871 | 0.180 |
Why?
|
| Kinetics | 10 | 2005 | 6312 | 0.170 |
Why?
|
| Plasmodium falciparum | 3 | 2015 | 1740 | 0.170 |
Why?
|
| TRPV Cation Channels | 1 | 2021 | 243 | 0.170 |
Why?
|
| Okadaic Acid | 4 | 2006 | 67 | 0.170 |
Why?
|
| Patch-Clamp Techniques | 7 | 2017 | 924 | 0.170 |
Why?
|
| Spleen | 3 | 2024 | 2290 | 0.170 |
Why?
|
| Blood Coagulation Tests | 2 | 2019 | 271 | 0.170 |
Why?
|
| Research Support as Topic | 4 | 2011 | 697 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2019 | 3388 | 0.170 |
Why?
|
| Endothelins | 1 | 1999 | 127 | 0.170 |
Why?
|
| Mutation | 15 | 2021 | 30002 | 0.160 |
Why?
|
| Integrases | 1 | 2022 | 518 | 0.160 |
Why?
|
| Cerebrospinal Fluid | 2 | 2017 | 544 | 0.160 |
Why?
|
| Plasmodium vivax | 1 | 2021 | 202 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 23 | 2019 | 22127 | 0.160 |
Why?
|
| Oxygen | 7 | 2015 | 4227 | 0.160 |
Why?
|
| Malaria, Vivax | 1 | 2021 | 166 | 0.160 |
Why?
|
| Mice, Knockout | 16 | 2021 | 14392 | 0.160 |
Why?
|
| Enzyme Inhibitors | 7 | 2013 | 3702 | 0.160 |
Why?
|
| Phagocytosis | 1 | 2024 | 1525 | 0.160 |
Why?
|
| Industry | 5 | 2011 | 364 | 0.160 |
Why?
|
| Immune System Diseases | 1 | 2021 | 255 | 0.160 |
Why?
|
| Iron Chelating Agents | 2 | 1999 | 141 | 0.160 |
Why?
|
| Leukocyte Count | 5 | 2019 | 1597 | 0.160 |
Why?
|
| Hypertonic Solutions | 3 | 2006 | 82 | 0.150 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2019 | 540 | 0.150 |
Why?
|
| Blood Viscosity | 1 | 2018 | 124 | 0.150 |
Why?
|
| Biomedical Research | 8 | 2012 | 3434 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 3 | 2006 | 2478 | 0.150 |
Why?
|
| Injections, Intravenous | 4 | 2012 | 1376 | 0.150 |
Why?
|
| Host-Parasite Interactions | 3 | 2015 | 300 | 0.150 |
Why?
|
| Ionophores | 4 | 2011 | 107 | 0.150 |
Why?
|
| Cell Membrane Permeability | 8 | 2001 | 573 | 0.150 |
Why?
|
| Acoustics | 1 | 2019 | 243 | 0.150 |
Why?
|
| Furosemide | 7 | 1988 | 170 | 0.140 |
Why?
|
| Glutamine | 1 | 2020 | 574 | 0.140 |
Why?
|
| Membrane Potentials | 6 | 2019 | 1088 | 0.140 |
Why?
|
| Mice, Inbred DBA | 5 | 2010 | 623 | 0.140 |
Why?
|
| Rabbits | 10 | 2012 | 4750 | 0.140 |
Why?
|
| Crosses, Genetic | 4 | 2010 | 752 | 0.140 |
Why?
|
| Globins | 4 | 1997 | 405 | 0.140 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2014 | 788 | 0.140 |
Why?
|
| Peptides | 4 | 2010 | 4353 | 0.140 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 386 | 0.140 |
Why?
|
| Iron, Dietary | 1 | 2017 | 148 | 0.140 |
Why?
|
| src-Family Kinases | 4 | 2008 | 535 | 0.140 |
Why?
|
| Phenylhydrazines | 2 | 1994 | 28 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 1 | 2008 | 1592 | 0.140 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 858 | 0.140 |
Why?
|
| Brain Damage, Chronic | 1 | 1997 | 266 | 0.140 |
Why?
|
| Antioxidants | 1 | 2004 | 1667 | 0.140 |
Why?
|
| Adult | 46 | 2024 | 221119 | 0.130 |
Why?
|
| Nutritional Requirements | 1 | 2017 | 274 | 0.130 |
Why?
|
| Cell Fractionation | 1 | 2016 | 248 | 0.130 |
Why?
|
| Trophozoites | 1 | 2015 | 12 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 7400 | 0.130 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2017 | 182 | 0.130 |
Why?
|
| Drug Industry | 3 | 2010 | 788 | 0.130 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2024 | 1605 | 0.130 |
Why?
|
| Child, Preschool | 14 | 2021 | 42224 | 0.130 |
Why?
|
| Plasmodium yoelii | 1 | 2015 | 41 | 0.130 |
Why?
|
| Itraconazole | 1 | 1995 | 43 | 0.130 |
Why?
|
| Quinolines | 1 | 2021 | 764 | 0.130 |
Why?
|
| Calcium Channels | 2 | 2010 | 620 | 0.120 |
Why?
|
| 2,3-Diphosphoglycerate | 1 | 2014 | 13 | 0.120 |
Why?
|
| Receptors, Drug | 1 | 1995 | 157 | 0.120 |
Why?
|
| Species Specificity | 4 | 2013 | 2406 | 0.120 |
Why?
|
| Blood Coagulation | 2 | 2019 | 1156 | 0.120 |
Why?
|
| Receptor, TIE-2 | 1 | 2015 | 176 | 0.120 |
Why?
|
| Rubidium | 5 | 2011 | 121 | 0.120 |
Why?
|
| Diarrhea | 2 | 2021 | 1316 | 0.120 |
Why?
|
| Kidney Diseases | 4 | 2018 | 2092 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2024 | 3634 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2012 | 5333 | 0.120 |
Why?
|
| Malaria, Falciparum | 2 | 2015 | 1076 | 0.120 |
Why?
|
| Body Water | 4 | 2001 | 340 | 0.120 |
Why?
|
| Reproducibility of Results | 7 | 2021 | 20119 | 0.120 |
Why?
|
| Isotonic Solutions | 2 | 2006 | 117 | 0.120 |
Why?
|
| Fibrinogen | 2 | 1998 | 888 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2002 | 1249 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2015 | 23416 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2018 | 1487 | 0.110 |
Why?
|
| Hypophosphatemia | 1 | 2014 | 92 | 0.110 |
Why?
|
| Pyridones | 2 | 1999 | 809 | 0.110 |
Why?
|
| Sulfhydryl Compounds | 1 | 1995 | 296 | 0.110 |
Why?
|
| Mutagenesis | 2 | 2017 | 1226 | 0.110 |
Why?
|
| Child | 20 | 2021 | 80152 | 0.110 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 132 | 0.110 |
Why?
|
| Blood Preservation | 1 | 2014 | 169 | 0.110 |
Why?
|
| Phylogeny | 1 | 2021 | 2809 | 0.110 |
Why?
|
| Electrolytes | 2 | 1985 | 274 | 0.110 |
Why?
|
| Immunoassay | 1 | 1997 | 743 | 0.110 |
Why?
|
| Lithium | 6 | 1993 | 596 | 0.110 |
Why?
|
| Endothelin-1 | 3 | 2015 | 302 | 0.110 |
Why?
|
| Adolescent | 20 | 2021 | 88298 | 0.110 |
Why?
|
| Protein Kinase C | 3 | 2004 | 1202 | 0.110 |
Why?
|
| Equipment Design | 1 | 2021 | 3510 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 246 | 0.100 |
Why?
|
| Priapism | 1 | 2012 | 28 | 0.100 |
Why?
|
| Stilbenes | 1 | 2013 | 155 | 0.100 |
Why?
|
| History, 21st Century | 2 | 2016 | 1567 | 0.100 |
Why?
|
| Chronic Disease | 3 | 2008 | 9319 | 0.100 |
Why?
|
| Renal Replacement Therapy | 1 | 2014 | 281 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2802 | 0.100 |
Why?
|
| Mice, Mutant Strains | 4 | 2012 | 1751 | 0.100 |
Why?
|
| Immersion | 1 | 1992 | 37 | 0.100 |
Why?
|
| Stem Cells | 2 | 2015 | 3517 | 0.100 |
Why?
|
| Alleles | 4 | 2018 | 6857 | 0.100 |
Why?
|
| Docosahexaenoic Acids | 1 | 2018 | 906 | 0.100 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2731 | 0.100 |
Why?
|
| Zoonoses | 1 | 2013 | 179 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2012 | 313 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 1 | 1997 | 710 | 0.100 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 12976 | 0.100 |
Why?
|
| Calcimycin | 4 | 2022 | 213 | 0.090 |
Why?
|
| Bone Marrow | 2 | 2021 | 2911 | 0.090 |
Why?
|
| Hemochromatosis | 2 | 2008 | 174 | 0.090 |
Why?
|
| Boston | 1 | 2024 | 9327 | 0.090 |
Why?
|
| Chemistry, Clinical | 3 | 2011 | 64 | 0.090 |
Why?
|
| Erythroid Precursor Cells | 5 | 2019 | 212 | 0.090 |
Why?
|
| Cytokines | 3 | 2018 | 7386 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2024 | 1390 | 0.090 |
Why?
|
| Skin Ulcer | 1 | 2012 | 130 | 0.090 |
Why?
|
| Mice, Inbred C3H | 2 | 2010 | 914 | 0.090 |
Why?
|
| Receptors, Endothelin | 2 | 2002 | 56 | 0.090 |
Why?
|
| Receptor, Endothelin B | 2 | 2002 | 45 | 0.090 |
Why?
|
| Mice, Inbred A | 1 | 2010 | 245 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2016 | 2765 | 0.090 |
Why?
|
| Heme | 1 | 2012 | 313 | 0.090 |
Why?
|
| Reagent Kits, Diagnostic | 4 | 2012 | 239 | 0.090 |
Why?
|
| Family | 2 | 2019 | 3192 | 0.090 |
Why?
|
| Pathology, Clinical | 2 | 2006 | 376 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2021 | 3537 | 0.090 |
Why?
|
| Hydrogen | 2 | 2006 | 172 | 0.090 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 284 | 0.090 |
Why?
|
| Dipyridamole | 2 | 2010 | 142 | 0.090 |
Why?
|
| Microwaves | 1 | 1992 | 184 | 0.090 |
Why?
|
| Infant | 11 | 2021 | 36169 | 0.090 |
Why?
|
| Laboratories | 2 | 2011 | 462 | 0.090 |
Why?
|
| Young Adult | 8 | 2021 | 59221 | 0.090 |
Why?
|
| Spider Venoms | 1 | 2010 | 43 | 0.090 |
Why?
|
| Sensitivity and Specificity | 6 | 2017 | 14675 | 0.090 |
Why?
|
| Chemokine CCL5 | 2 | 2002 | 214 | 0.090 |
Why?
|
| Milk Proteins | 2 | 2001 | 162 | 0.090 |
Why?
|
| Base Sequence | 12 | 2019 | 12404 | 0.080 |
Why?
|
| Polymorphism, Genetic | 3 | 2015 | 4243 | 0.080 |
Why?
|
| Vascular Malformations | 1 | 2015 | 468 | 0.080 |
Why?
|
| Electric Conductivity | 3 | 2008 | 405 | 0.080 |
Why?
|
| Macrophages | 1 | 2024 | 5753 | 0.080 |
Why?
|
| Rubidium Radioisotopes | 3 | 2009 | 97 | 0.080 |
Why?
|
| Biological Transport, Active | 4 | 1998 | 323 | 0.080 |
Why?
|
| Nystatin | 3 | 2011 | 22 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2015 | 1111 | 0.080 |
Why?
|
| Leukocytes | 1 | 2017 | 2025 | 0.080 |
Why?
|
| Reference Standards | 3 | 2021 | 1005 | 0.080 |
Why?
|
| Financing, Organized | 1 | 2010 | 204 | 0.080 |
Why?
|
| Mice, Inbred Strains | 4 | 2005 | 1762 | 0.080 |
Why?
|
| Microfilament Proteins | 2 | 2006 | 1130 | 0.080 |
Why?
|
| Cell Separation | 1 | 2014 | 1721 | 0.080 |
Why?
|
| Antimalarials | 1 | 2015 | 907 | 0.080 |
Why?
|
| Research Report | 1 | 2012 | 367 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2270 | 0.080 |
Why?
|
| Erythrocyte Aggregation | 2 | 2006 | 35 | 0.080 |
Why?
|
| Valinomycin | 1 | 2008 | 17 | 0.080 |
Why?
|
| Academies and Institutes | 1 | 2011 | 318 | 0.080 |
Why?
|
| Plasma | 1 | 1992 | 586 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 3 | 2005 | 1334 | 0.080 |
Why?
|
| Vascular Diseases | 2 | 2015 | 1160 | 0.080 |
Why?
|
| Pain | 2 | 2020 | 5072 | 0.080 |
Why?
|
| Water | 4 | 2015 | 1410 | 0.080 |
Why?
|
| Acidosis, Renal Tubular | 2 | 1998 | 50 | 0.080 |
Why?
|
| Rolipram | 1 | 2008 | 24 | 0.080 |
Why?
|
| Oxidation-Reduction | 4 | 2012 | 2227 | 0.080 |
Why?
|
| Renal Dialysis | 3 | 2004 | 1796 | 0.080 |
Why?
|
| Papio | 2 | 2007 | 669 | 0.080 |
Why?
|
| Sirolimus | 1 | 2015 | 1540 | 0.080 |
Why?
|
| Arginine | 2 | 2006 | 920 | 0.080 |
Why?
|
| Homeostasis | 3 | 2018 | 3320 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3803 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 1348 | 0.070 |
Why?
|
| Internship and Residency | 3 | 2006 | 5885 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 656 | 0.070 |
Why?
|
| Clinical Trials as Topic | 3 | 2015 | 8003 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 3092 | 0.070 |
Why?
|
| Curriculum | 2 | 2006 | 3741 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2023 | 4642 | 0.070 |
Why?
|
| Treatment Outcome | 7 | 2021 | 64681 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 2000 | 4413 | 0.070 |
Why?
|
| Endothelium, Vascular | 5 | 2015 | 4420 | 0.070 |
Why?
|
| Cells, Cultured | 9 | 2022 | 18926 | 0.070 |
Why?
|
| Dialysis | 1 | 2006 | 73 | 0.070 |
Why?
|
| Charybdotoxin | 3 | 1997 | 23 | 0.070 |
Why?
|
| Sulfates | 4 | 2011 | 378 | 0.070 |
Why?
|
| Infant, Newborn | 5 | 2011 | 26199 | 0.070 |
Why?
|
| Pneumonia | 1 | 2018 | 2142 | 0.070 |
Why?
|
| Membrane Transport Modulators | 1 | 2006 | 24 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 974 | 0.070 |
Why?
|
| Structure-Activity Relationship | 4 | 2016 | 3057 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 808 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2010 | 6199 | 0.070 |
Why?
|
| Carbon Monoxide | 1 | 2010 | 547 | 0.070 |
Why?
|
| Growth Inhibitors | 2 | 1999 | 374 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3417 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2009 | 684 | 0.060 |
Why?
|
| ROC Curve | 3 | 2014 | 3584 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 1997 | 2642 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 1301 | 0.060 |
Why?
|
| Drug Evaluation | 2 | 2006 | 641 | 0.060 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 2 | 2017 | 17 | 0.060 |
Why?
|
| Chromosome Mapping | 2 | 2007 | 4612 | 0.060 |
Why?
|
| Heterozygote | 4 | 2017 | 2778 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 13632 | 0.060 |
Why?
|
| Fas Ligand Protein | 1 | 2006 | 216 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 1812 | 0.060 |
Why?
|
| Peroxynitrous Acid | 1 | 2005 | 40 | 0.060 |
Why?
|
| Furaldehyde | 1 | 2005 | 5 | 0.060 |
Why?
|
| Cell Adhesion | 3 | 2011 | 3091 | 0.060 |
Why?
|
| Protein Phosphatase 1 | 1 | 2005 | 134 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2058 | 0.060 |
Why?
|
| Hydroxyethylrutoside | 1 | 2004 | 4 | 0.060 |
Why?
|
| Temperature | 1 | 1992 | 2219 | 0.060 |
Why?
|
| Anemia, Sideroblastic | 2 | 2012 | 109 | 0.060 |
Why?
|
| Annexins | 1 | 2004 | 38 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1999 | 298 | 0.060 |
Why?
|
| Molecular Sequence Data | 10 | 2013 | 17598 | 0.060 |
Why?
|
| Spectrin | 3 | 2002 | 170 | 0.060 |
Why?
|
| Gene Targeting | 4 | 2004 | 838 | 0.060 |
Why?
|
| Platelet Count | 2 | 2005 | 782 | 0.060 |
Why?
|
| Adolescent Medicine | 1 | 2005 | 73 | 0.060 |
Why?
|
| Amino Acid Substitution | 3 | 2016 | 1737 | 0.060 |
Why?
|
| Genome-Wide Association Study | 3 | 2023 | 12676 | 0.060 |
Why?
|
| Publishing | 1 | 2012 | 832 | 0.060 |
Why?
|
| Receptors, Transferrin | 2 | 2003 | 291 | 0.060 |
Why?
|
| Codon | 3 | 2016 | 597 | 0.060 |
Why?
|
| Phosphorylation | 4 | 2005 | 8300 | 0.060 |
Why?
|
| Lipoproteins, HDL | 2 | 2002 | 675 | 0.060 |
Why?
|
| Renin | 2 | 1983 | 639 | 0.060 |
Why?
|
| Time Factors | 10 | 2019 | 39957 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2254 | 0.060 |
Why?
|
| Forecasting | 1 | 2012 | 2928 | 0.050 |
Why?
|
| Pedigree | 4 | 2014 | 4537 | 0.050 |
Why?
|
| Blood Cells | 1 | 2005 | 306 | 0.050 |
Why?
|
| Chromosomes | 1 | 2006 | 578 | 0.050 |
Why?
|
| Xenopus laevis | 3 | 2013 | 962 | 0.050 |
Why?
|
| Platelet Aggregation | 1 | 2006 | 771 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 631 | 0.050 |
Why?
|
| Acetic Acid | 1 | 2022 | 59 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 411 | 0.050 |
Why?
|
| K562 Cells | 2 | 2015 | 640 | 0.050 |
Why?
|
| Cell Differentiation | 7 | 2021 | 11509 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4190 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2640 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 1923 | 0.050 |
Why?
|
| Suramin | 1 | 2022 | 34 | 0.050 |
Why?
|
| Amino Acid Sequence | 7 | 2019 | 13402 | 0.050 |
Why?
|
| Probenecid | 1 | 2022 | 73 | 0.050 |
Why?
|
| Chloride Channels | 2 | 2001 | 221 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 7966 | 0.050 |
Why?
|
| Gene Deletion | 3 | 2021 | 2658 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2008 | 4111 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2008 | 2426 | 0.050 |
Why?
|
| Hypotonic Solutions | 3 | 1998 | 48 | 0.050 |
Why?
|
| Platelet Activating Factor | 1 | 2002 | 143 | 0.050 |
Why?
|
| Calcium Signaling | 2 | 2019 | 731 | 0.050 |
Why?
|
| Cell Survival | 4 | 2019 | 5778 | 0.050 |
Why?
|
| Phenotype | 8 | 2019 | 16575 | 0.050 |
Why?
|
| Middle Aged | 20 | 2024 | 220853 | 0.050 |
Why?
|
| Phthalic Acids | 1 | 2006 | 478 | 0.050 |
Why?
|
| Bilirubin | 2 | 2012 | 436 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 2000 | 958 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 1558 | 0.050 |
Why?
|
| Benzaldehydes | 1 | 2021 | 59 | 0.050 |
Why?
|
| Permeability | 2 | 2021 | 721 | 0.050 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2002 | 284 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 1168 | 0.050 |
Why?
|
| Track and Field | 1 | 2000 | 11 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2001 | 2846 | 0.050 |
Why?
|
| Boxing | 1 | 2000 | 17 | 0.050 |
Why?
|
| Dinucleotide Repeats | 1 | 2000 | 28 | 0.040 |
Why?
|
| Urea | 1 | 2003 | 442 | 0.040 |
Why?
|
| Neoplasms | 2 | 2008 | 22140 | 0.040 |
Why?
|
| Kidney Concentrating Ability | 1 | 2000 | 34 | 0.040 |
Why?
|
| Oxyhemoglobins | 3 | 2014 | 212 | 0.040 |
Why?
|
| Stroke | 1 | 2023 | 9721 | 0.040 |
Why?
|
| Tyrosine | 1 | 2005 | 1422 | 0.040 |
Why?
|
| Hypertension | 7 | 1987 | 8536 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2022 | 4243 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3696 | 0.040 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1998 | 176 | 0.040 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2024 | 561 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2019 | 17897 | 0.040 |
Why?
|
| Vitamin E | 1 | 2004 | 872 | 0.040 |
Why?
|
| Marine Toxins | 1 | 1999 | 24 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2021 | 22174 | 0.040 |
Why?
|
| DNA, Complementary | 6 | 1999 | 1989 | 0.040 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2001 | 109 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 15308 | 0.040 |
Why?
|
| Magnesium Deficiency | 2 | 1997 | 48 | 0.040 |
Why?
|
| Point Mutation | 2 | 1995 | 1593 | 0.040 |
Why?
|
| Clinical Chemistry Tests | 1 | 2020 | 59 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2003 | 1159 | 0.040 |
Why?
|
| Genotype | 4 | 2023 | 12985 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 420 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2002 | 487 | 0.040 |
Why?
|
| Adenosine Triphosphate | 3 | 2022 | 1988 | 0.040 |
Why?
|
| Swimming | 1 | 2000 | 208 | 0.040 |
Why?
|
| Methylation | 1 | 2002 | 1070 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 2138 | 0.040 |
Why?
|
| Mitochondria | 1 | 2012 | 3620 | 0.040 |
Why?
|
| Apyrase | 1 | 2022 | 373 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2001 | 525 | 0.040 |
Why?
|
| Pediatrics | 2 | 2006 | 3590 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2013 | 2740 | 0.040 |
Why?
|
| Splenomegaly | 1 | 2019 | 191 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2015 | 8642 | 0.040 |
Why?
|
| Bicycling | 1 | 2000 | 177 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2001 | 9566 | 0.040 |
Why?
|
| Blood Transfusion | 3 | 2021 | 1303 | 0.040 |
Why?
|
| Solubility | 1 | 2001 | 1085 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2000 | 332 | 0.040 |
Why?
|
| Threonine | 1 | 1999 | 270 | 0.040 |
Why?
|
| DNA Primers | 3 | 2007 | 2814 | 0.040 |
Why?
|
| Oscillometry | 1 | 2019 | 150 | 0.040 |
Why?
|
| Naphthalenes | 1 | 1999 | 198 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 654 | 0.040 |
Why?
|
| Viscosity | 1 | 2019 | 335 | 0.040 |
Why?
|
| Teaching | 1 | 2006 | 1171 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2007 | 2881 | 0.040 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 1998 | 65 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2871 | 0.040 |
Why?
|
| Oxazoles | 1 | 1999 | 199 | 0.040 |
Why?
|
| gamma-Globins | 1 | 2019 | 105 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1999 | 233 | 0.040 |
Why?
|
| Aged | 9 | 2021 | 169288 | 0.040 |
Why?
|
| Zebrafish | 4 | 2012 | 3000 | 0.040 |
Why?
|
| Ribavirin | 1 | 2000 | 394 | 0.040 |
Why?
|
| Anemia, Megaloblastic | 1 | 1998 | 24 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2011 | 12341 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 2897 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2005 | 4513 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2019 | 265 | 0.040 |
Why?
|
| Down-Regulation | 3 | 2014 | 2916 | 0.040 |
Why?
|
| Ischemia | 1 | 2006 | 1889 | 0.040 |
Why?
|
| Anions | 2 | 1988 | 133 | 0.040 |
Why?
|
| Proteins | 1 | 2012 | 5993 | 0.040 |
Why?
|
| Meningococcal Infections | 1 | 1998 | 77 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 2001 | 529 | 0.040 |
Why?
|
| Protein C | 1 | 1998 | 133 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 2015 | 2328 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2020 | 80674 | 0.040 |
Why?
|
| Streptokinase | 1 | 1997 | 186 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2021 | 665 | 0.040 |
Why?
|
| Hemoglobin C | 2 | 1989 | 21 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 1997 | 225 | 0.040 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 1997 | 91 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2000 | 324 | 0.040 |
Why?
|
| Cations, Divalent | 2 | 1987 | 167 | 0.040 |
Why?
|
| Xenopus | 4 | 2000 | 709 | 0.040 |
Why?
|
| Elasticity | 1 | 2019 | 655 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2002 | 774 | 0.030 |
Why?
|
| Thrombelastography | 1 | 2019 | 187 | 0.030 |
Why?
|
| Genome | 3 | 2000 | 1738 | 0.030 |
Why?
|
| Drug Therapy, Combination | 4 | 2021 | 6304 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1997 | 130 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2007 | 7571 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 3821 | 0.030 |
Why?
|
| Athletic Performance | 1 | 2017 | 111 | 0.030 |
Why?
|
| United States | 6 | 2017 | 72339 | 0.030 |
Why?
|
| Sound | 1 | 2018 | 258 | 0.030 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 105 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1997 | 325 | 0.030 |
Why?
|
| Cloning, Molecular | 5 | 2000 | 4167 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2001 | 1404 | 0.030 |
Why?
|
| Cytosol | 1 | 1999 | 883 | 0.030 |
Why?
|
| Trace Elements | 1 | 2018 | 193 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2013 | 10756 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2002 | 1176 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2002 | 1179 | 0.030 |
Why?
|
| Cations, Monovalent | 2 | 2013 | 24 | 0.030 |
Why?
|
| Food, Fortified | 1 | 1997 | 189 | 0.030 |
Why?
|
| Uremia | 1 | 1997 | 202 | 0.030 |
Why?
|
| Menstruation | 1 | 2017 | 307 | 0.030 |
Why?
|
| Sodium Channels | 1 | 1998 | 339 | 0.030 |
Why?
|
| Research Design | 1 | 2012 | 6180 | 0.030 |
Why?
|
| Family Health | 1 | 2001 | 1254 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 1995 | 93 | 0.030 |
Why?
|
| Imidazoline Receptors | 1 | 1995 | 13 | 0.030 |
Why?
|
| Vitamins | 1 | 2004 | 1634 | 0.030 |
Why?
|
| Bone Marrow Diseases | 1 | 1998 | 233 | 0.030 |
Why?
|
| Serine | 1 | 1999 | 826 | 0.030 |
Why?
|
| Acetonitriles | 1 | 1995 | 54 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 1408 | 0.030 |
Why?
|
| Cell Line | 6 | 2016 | 15545 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 174 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1360 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-hck | 2 | 2005 | 46 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2006 | 4165 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1998 | 850 | 0.030 |
Why?
|
| Benzofurans | 1 | 1996 | 139 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2017 | 1331 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2021 | 41496 | 0.030 |
Why?
|
| Volatilization | 1 | 2014 | 76 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2004 | 4537 | 0.030 |
Why?
|
| Tetrazoles | 1 | 2001 | 909 | 0.030 |
Why?
|
| Pyrazines | 1 | 2021 | 1202 | 0.030 |
Why?
|
| Proteomics | 1 | 2008 | 3840 | 0.030 |
Why?
|
| Monomethylhydrazine | 1 | 1994 | 1 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2005 | 2477 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2014 | 245 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2014 | 110 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2020 | 1010 | 0.030 |
Why?
|
| Interleukins | 1 | 1999 | 782 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2023 | 1387 | 0.030 |
Why?
|
| Portal Vein | 1 | 1997 | 432 | 0.030 |
Why?
|
| Centrifugation | 1 | 2014 | 122 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2006 | 2746 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 4 | 2001 | 6067 | 0.030 |
Why?
|
| Neurotoxins | 1 | 1995 | 240 | 0.030 |
Why?
|
| Guidelines as Topic | 2 | 2011 | 1385 | 0.030 |
Why?
|
| alpha-Globins | 1 | 2014 | 19 | 0.030 |
Why?
|
| Regression Analysis | 3 | 2005 | 6345 | 0.030 |
Why?
|
| Freeze Fracturing | 1 | 1994 | 70 | 0.030 |
Why?
|
| Neutrophils | 2 | 2018 | 3763 | 0.030 |
Why?
|
| Oocytes | 3 | 2009 | 1165 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2020 | 2854 | 0.030 |
Why?
|
| Zambia | 1 | 2014 | 271 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 2 | 1991 | 105 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 1682 | 0.030 |
Why?
|
| Splenectomy | 1 | 2015 | 391 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 1780 | 0.030 |
Why?
|
| Adult Children | 1 | 2014 | 103 | 0.030 |
Why?
|
| Blood Banks | 1 | 2014 | 108 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2006 | 3551 | 0.030 |
Why?
|
| Models, Biological | 2 | 2024 | 9457 | 0.030 |
Why?
|
| RNA | 3 | 1999 | 2709 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 1998 | 1080 | 0.030 |
Why?
|
| Feedback | 1 | 1997 | 790 | 0.030 |
Why?
|
| Peroxiredoxins | 1 | 2013 | 51 | 0.030 |
Why?
|
| Antigens | 1 | 1999 | 1441 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2022 | 5773 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 370 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 1999 | 1187 | 0.030 |
Why?
|
| Ferrous Compounds | 1 | 1993 | 41 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2002 | 2444 | 0.030 |
Why?
|
| Piperidines | 1 | 2002 | 1656 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 1997 | 637 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2002 | 1855 | 0.030 |
Why?
|
| Catalase | 1 | 2013 | 217 | 0.030 |
Why?
|
| Bucladesine | 1 | 2012 | 118 | 0.030 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1989 | 33 | 0.030 |
Why?
|
| Methazolamide | 2 | 1989 | 9 | 0.030 |
Why?
|
| RNA, Messenger | 5 | 2006 | 12747 | 0.030 |
Why?
|
| Ferrochelatase | 1 | 2012 | 47 | 0.030 |
Why?
|
| Total Quality Management | 1 | 1994 | 262 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2018 | 24021 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 2015 | 428 | 0.030 |
Why?
|
| Kidney | 4 | 2009 | 7033 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2003 | 3549 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 1994 | 672 | 0.030 |
Why?
|
| Drug Resistance | 2 | 1995 | 1594 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1997 | 1488 | 0.030 |
Why?
|
| Financial Management | 1 | 1994 | 160 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 1217 | 0.030 |
Why?
|
| Isoelectric Point | 1 | 1992 | 76 | 0.030 |
Why?
|
| Sheep | 3 | 1990 | 1436 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2012 | 188 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2014 | 718 | 0.020 |
Why?
|
| Intestinal Mucosa | 3 | 2000 | 3031 | 0.020 |
Why?
|
| Cell Division | 2 | 2000 | 4451 | 0.020 |
Why?
|
| Calorimetry | 1 | 1992 | 129 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2015 | 307 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2012 | 252 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 556 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 2000 | 1027 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 1995 | 643 | 0.020 |
Why?
|
| Cytoskeleton | 2 | 2012 | 1169 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1997 | 1162 | 0.020 |
Why?
|
| Nitrates | 1 | 1993 | 260 | 0.020 |
Why?
|
| Liver | 2 | 2019 | 7514 | 0.020 |
Why?
|
| Societies | 1 | 2012 | 107 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2016 | 5406 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 4107 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1882 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2012 | 410 | 0.020 |
Why?
|
| Gestational Age | 1 | 2000 | 3580 | 0.020 |
Why?
|
| Shock, Septic | 1 | 1998 | 769 | 0.020 |
Why?
|
| Malaria | 1 | 2021 | 1225 | 0.020 |
Why?
|
| Quality Control | 1 | 1994 | 833 | 0.020 |
Why?
|
| Treatment Failure | 1 | 1997 | 2643 | 0.020 |
Why?
|
| Mesylates | 1 | 2011 | 37 | 0.020 |
Why?
|
| Veins | 1 | 2015 | 767 | 0.020 |
Why?
|
| Ethics Committees | 1 | 2010 | 51 | 0.020 |
Why?
|
| Freezing | 1 | 1992 | 311 | 0.020 |
Why?
|
| Rural Health Services | 1 | 2014 | 384 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1995 | 1417 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 1995 | 833 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1997 | 2359 | 0.020 |
Why?
|
| Algorithms | 2 | 2008 | 14025 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2008 | 5493 | 0.020 |
Why?
|
| Methylamines | 1 | 2011 | 136 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 696 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2021 | 2010 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 2561 | 0.020 |
Why?
|
| Complement Activation | 2 | 1989 | 445 | 0.020 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2010 | 168 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 11856 | 0.020 |
Why?
|
| Publication Bias | 1 | 2010 | 160 | 0.020 |
Why?
|
| Scientific Misconduct | 1 | 2010 | 74 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 1993 | 524 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 1998 | 2692 | 0.020 |
Why?
|
| Transfection | 2 | 2013 | 5748 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 2 | 2001 | 266 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 5662 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2451 | 0.020 |
Why?
|
| Biological Availability | 2 | 2005 | 389 | 0.020 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 1989 | 22 | 0.020 |
Why?
|
| RNA, Complementary | 1 | 2009 | 45 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 1995 | 961 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2015 | 992 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 3605 | 0.020 |
Why?
|
| bcl-X Protein | 2 | 2001 | 410 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1994 | 1664 | 0.020 |
Why?
|
| Inflammation | 1 | 2008 | 10759 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2015 | 1348 | 0.020 |
Why?
|
| Triglycerides | 2 | 1995 | 2457 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 794 | 0.020 |
Why?
|
| Intestines | 1 | 1997 | 1908 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2009 | 641 | 0.020 |
Why?
|
| Chloride-Bicarbonate Antiporters | 2 | 1998 | 103 | 0.020 |
Why?
|
| Colon | 1 | 1996 | 1791 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1997 | 2055 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 1246 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 3933 | 0.020 |
Why?
|
| Electrocoagulation | 1 | 2008 | 151 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2019 | 2974 | 0.020 |
Why?
|
| Particle Size | 1 | 2012 | 1649 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2014 | 12099 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 1067 | 0.020 |
Why?
|
| Prevalence | 3 | 2017 | 15721 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 77 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2000 | 3048 | 0.020 |
Why?
|
| Troponin I | 1 | 2012 | 652 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2014 | 1231 | 0.020 |
Why?
|
| Gene Expression | 2 | 2016 | 7571 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 1668 | 0.020 |
Why?
|
| Graft Survival | 1 | 1998 | 3843 | 0.020 |
Why?
|
| Apoptosis | 2 | 2001 | 9477 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2171 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1728 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 1334 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2455 | 0.020 |
Why?
|
| Mice, Inbred NZB | 1 | 2006 | 57 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 3596 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 361 | 0.020 |
Why?
|
| Bradykinin | 1 | 1986 | 205 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3412 | 0.020 |
Why?
|
| Folic Acid | 1 | 1993 | 1323 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2006 | 153 | 0.020 |
Why?
|
| Glycosylation | 2 | 1999 | 1095 | 0.020 |
Why?
|
| Electrophysiology | 2 | 2004 | 1262 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 430 | 0.020 |
Why?
|
| Drug Combinations | 2 | 2007 | 2048 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2000 | 2263 | 0.020 |
Why?
|
| Molsidomine | 1 | 2005 | 22 | 0.020 |
Why?
|
| Intracellular Fluid | 2 | 1996 | 201 | 0.020 |
Why?
|
| Data Collection | 1 | 2014 | 3320 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 1967 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 1988 | 737 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2014 | 2548 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 3 | 1998 | 6124 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2007 | 883 | 0.020 |
Why?
|
| Lod Score | 1 | 2005 | 600 | 0.020 |
Why?
|
| Markov Chains | 1 | 2008 | 965 | 0.020 |
Why?
|
| Vasopressins | 1 | 1986 | 351 | 0.010 |
Why?
|
| DNA | 2 | 2000 | 7189 | 0.010 |
Why?
|
| Homozygote | 1 | 1989 | 1775 | 0.010 |
Why?
|
| Hypertension, Renal | 2 | 1986 | 135 | 0.010 |
Why?
|
| Autoanalysis | 1 | 2004 | 70 | 0.010 |
Why?
|
| Ergotamines | 1 | 1984 | 4 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1987 | 540 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 5782 | 0.010 |
Why?
|
| Blood Volume | 1 | 2005 | 547 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 1401 | 0.010 |
Why?
|
| Exons | 2 | 2000 | 2380 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2011 | 5032 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1997 | 39126 | 0.010 |
Why?
|
| Endothelium | 1 | 1986 | 763 | 0.010 |
Why?
|
| Parotid Gland | 1 | 2004 | 176 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 2000 | 2665 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1984 | 181 | 0.010 |
Why?
|
| Inheritance Patterns | 1 | 2005 | 341 | 0.010 |
Why?
|
| Prognosis | 2 | 2008 | 29687 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2012 | 1977 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1651 | 0.010 |
Why?
|
| Genome, Human | 1 | 2015 | 4423 | 0.010 |
Why?
|
| Rats | 4 | 2001 | 23704 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1994 | 1923 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 2465 | 0.010 |
Why?
|
| Mitosis | 1 | 2007 | 1186 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 940 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3778 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2002 | 85 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 601 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2005 | 54435 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 2001 | 104 | 0.010 |
Why?
|
| Receptors, Lipoprotein | 1 | 2002 | 88 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2635 | 0.010 |
Why?
|
| Receptors, Scavenger | 1 | 2002 | 123 | 0.010 |
Why?
|
| Exercise | 1 | 2017 | 5874 | 0.010 |
Why?
|
| Health Personnel | 1 | 2014 | 3337 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1695 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 2000 | 32 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1993 | 3422 | 0.010 |
Why?
|
| Phagosomes | 1 | 2002 | 199 | 0.010 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2000 | 41 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5666 | 0.010 |
Why?
|
| Child Health Services | 1 | 2006 | 644 | 0.010 |
Why?
|
| Staurosporine | 1 | 2001 | 241 | 0.010 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2000 | 33 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 2000 | 26 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3726 | 0.010 |
Why?
|
| Risk Factors | 4 | 2014 | 74239 | 0.010 |
Why?
|
| Yolk Sac | 1 | 2000 | 79 | 0.010 |
Why?
|
| Drug Administration Schedule | 3 | 1994 | 4851 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 1985 | 771 | 0.010 |
Why?
|
| Saliva | 1 | 2004 | 828 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2000 | 438 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1986 | 705 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1984 | 749 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2008 | 2241 | 0.010 |
Why?
|
| Poly A | 1 | 1999 | 180 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1999 | 416 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2000 | 1053 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 3577 | 0.010 |
Why?
|
| Genes, Immediate-Early | 1 | 1999 | 102 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 2000 | 379 | 0.010 |
Why?
|
| Models, Genetic | 2 | 1999 | 3430 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2005 | 10088 | 0.010 |
Why?
|
| Friend murine leukemia virus | 1 | 1998 | 37 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1999 | 362 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 812 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4567 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2008 | 1936 | 0.010 |
Why?
|
| Enterocytes | 1 | 2000 | 220 | 0.010 |
Why?
|
| Renal Artery | 1 | 1980 | 351 | 0.010 |
Why?
|
| Diet | 1 | 1996 | 8048 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 1867 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 1999 | 251 | 0.010 |
Why?
|
| Complement C3 | 1 | 2000 | 434 | 0.010 |
Why?
|
| Ligands | 1 | 2005 | 3264 | 0.010 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1997 | 31 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 1997 | 55 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 1545 | 0.010 |
Why?
|
| Craniofacial Abnormalities | 1 | 2000 | 319 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 968 | 0.010 |
Why?
|
| Superior Cervical Ganglion | 1 | 1997 | 33 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1999 | 819 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 15920 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1999 | 1059 | 0.010 |
Why?
|
| Survival | 1 | 1998 | 161 | 0.010 |
Why?
|
| Prothrombin | 1 | 1998 | 192 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 2000 | 376 | 0.010 |
Why?
|
| Toxins, Biological | 1 | 1997 | 60 | 0.010 |
Why?
|
| Binding Sites | 2 | 1996 | 5988 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 1999 | 514 | 0.010 |
Why?
|
| 4-Aminopyridine | 1 | 1997 | 80 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1998 | 292 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1997 | 317 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 1997 | 204 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2001 | 1498 | 0.010 |
Why?
|
| Ferrets | 1 | 1997 | 177 | 0.010 |
Why?
|
| Glyburide | 1 | 1997 | 116 | 0.010 |
Why?
|
| Cholesterol | 2 | 2002 | 2902 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2000 | 811 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1998 | 418 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 237 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2000 | 904 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2000 | 580 | 0.010 |
Why?
|
| Interferons | 1 | 2000 | 702 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 2001 | 912 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2002 | 1443 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1998 | 622 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1998 | 782 | 0.010 |
Why?
|
| Cattle | 2 | 1995 | 3818 | 0.010 |
Why?
|
| Endotoxins | 1 | 1998 | 520 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2000 | 710 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 1141 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1997 | 413 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1997 | 392 | 0.010 |
Why?
|
| Actins | 1 | 2002 | 2046 | 0.010 |
Why?
|
| Miconazole | 1 | 1994 | 9 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1996 | 944 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 383 | 0.010 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1997 | 544 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1997 | 674 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 2468 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2001 | 1405 | 0.010 |
Why?
|
| Autophagy | 1 | 2002 | 1327 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1995 | 1083 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2000 | 1791 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2002 | 1893 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1997 | 1875 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1997 | 1848 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1996 | 638 | 0.010 |
Why?
|
| Sex Factors | 2 | 1986 | 10553 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1986 | 2795 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1998 | 2340 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1996 | 1462 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 2175 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 2091 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2000 | 2925 | 0.010 |
Why?
|
| Creatinine | 1 | 1997 | 1897 | 0.010 |
Why?
|
| Epithelium | 1 | 1996 | 1603 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1995 | 1216 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4372 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1996 | 1756 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1998 | 2599 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 12052 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6223 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1995 | 1162 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 2010 | 0.010 |
Why?
|
| Placenta | 1 | 2000 | 1711 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 2949 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1995 | 2621 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 9416 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 58952 | 0.010 |
Why?
|
| Electrochemistry | 1 | 1989 | 145 | 0.010 |
Why?
|
| Colloids | 1 | 1989 | 123 | 0.010 |
Why?
|
| Pregnancy | 2 | 2004 | 29893 | 0.000 |
Why?
|
| Osmotic Pressure | 1 | 1989 | 137 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1989 | 1308 | 0.000 |
Why?
|
| Neoplastic Stem Cells | 1 | 1995 | 1348 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1989 | 584 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 3770 | 0.000 |
Why?
|
| Lactates | 1 | 1987 | 401 | 0.000 |
Why?
|
| Membrane Lipids | 1 | 1987 | 251 | 0.000 |
Why?
|
| Umbilical Veins | 1 | 1986 | 423 | 0.000 |
Why?
|
| Kidney Tubules | 1 | 1987 | 448 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1997 | 9652 | 0.000 |
Why?
|
| Dogs | 1 | 1990 | 3832 | 0.000 |
Why?
|
| Obesity | 1 | 1987 | 12939 | 0.000 |
Why?
|
| Vasoconstriction | 1 | 1987 | 592 | 0.000 |
Why?
|
| Radioisotopes | 1 | 1986 | 502 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1997 | 4201 | 0.000 |
Why?
|
| Ergotamine | 1 | 1984 | 7 | 0.000 |
Why?
|
| Aging | 1 | 1983 | 8702 | 0.000 |
Why?
|
| Celiac Artery | 1 | 1984 | 65 | 0.000 |
Why?
|
| Thrombosis | 1 | 1998 | 2944 | 0.000 |
Why?
|
| Mesenteric Arteries | 1 | 1984 | 178 | 0.000 |
Why?
|
| Comorbidity | 1 | 1997 | 10516 | 0.000 |
Why?
|
| Brachial Artery | 1 | 1984 | 366 | 0.000 |
Why?
|
| Lactic Acid | 1 | 1987 | 1139 | 0.000 |
Why?
|
| Phospholipids | 1 | 1985 | 784 | 0.000 |
Why?
|
| Software | 1 | 1995 | 4431 | 0.000 |
Why?
|
| Aorta, Thoracic | 1 | 1986 | 1096 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1997 | 5842 | 0.000 |
Why?
|
| Melanoma | 1 | 1995 | 5694 | 0.000 |
Why?
|
| Lipids | 1 | 1987 | 3331 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1987 | 8479 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1995 | 13385 | 0.000 |
Why?
|
| Age Factors | 1 | 1986 | 18384 | 0.000 |
Why?
|
| Radiography | 1 | 1980 | 6974 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1982 | 15520 | 0.000 |
Why?
|